Skip to main content

Peer Review reports

From: Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

Original Submission
13 Feb 2013 Submitted Original manuscript
25 Jun 2013 Author responded Author comments - Dorothee M. Kieninger
12 Mar 2013 Reviewed Reviewer Report - Jiri Beran
6 May 2013 Reviewed Reviewer Report - Roman Prymula
Resubmission - Version 2
25 Jun 2013 Submitted Manuscript version 2
27 Jun 2013 Author responded Author comments - Dorothee M. Kieninger
Resubmission - Version 3
27 Jun 2013 Submitted Manuscript version 3
Publishing
15 Jul 2013 Editorially accepted
24 Jul 2013 Article published 10.1186/1471-2334-13-343

You can find further information about peer review here.

Back to article page
\